Toxicodynamics within the realm of biopharmaceutics explores the dynamic interactions between a drug and the body, focusing on the mechanisms that govern toxicity. Understanding toxicodynamics is crucial for assessing how a biopharmaceutical agent behaves within the biological system, influencing its absorption, distribution, metabolism, and excretion.
This facet of biopharmaceutics delves into the specific molecular and physiological responses to a drug, shedding light on potential adverse effects and establishing safe dosage parameters. Factors such as receptor binding, signal transduction pathways, and the overall impact on cellular function are key considerations in toxicodynamic assessments.
Researchers in biopharmaceutics strive to unravel the intricate web of toxicodynamic relationships to enhance drug safety and efficacy. By elucidating the mechanisms behind drug toxicity, the field contributes significantly to the development of pharmaceuticals with minimized adverse effects and optimized therapeutic outcomes. Toxicodynamics thus stands as a vital component in the comprehensive study of biopharmaceutics, ensuring that pharmaceutical interventions are not only effective but also safe for patient use.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand